185 related articles for article (PubMed ID: 12763518)
1. Hormone therapy and venous thromboembolism.
Peverill RE
Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):149-64. PubMed ID: 12763518
[TBL] [Abstract][Full Text] [Related]
2. [Hormone replacement therapy and venous thromboembolism].
Pavičić Baldani D; Skrgatić L; Simunić V; Elvedi Gasparović V; Geršak B
Lijec Vjesn; 2015; 137(1-2):34-40. PubMed ID: 25906547
[TBL] [Abstract][Full Text] [Related]
3. Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis.
Scarabin PY
Climacteric; 2018 Aug; 21(4):341-345. PubMed ID: 29570359
[TBL] [Abstract][Full Text] [Related]
4. Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
Eilertsen AL; Liestøl S; Mowinckel MC; Hemker HC; Sandset PM
Thromb Haemost; 2007 Jun; 97(6):938-43. PubMed ID: 17549295
[TBL] [Abstract][Full Text] [Related]
5. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
Canonico M
Maturitas; 2015 Nov; 82(3):304-7. PubMed ID: 26276103
[TBL] [Abstract][Full Text] [Related]
6. [Thrombophilic syndrome associated to phenotypic resistance to activated protein C in postmenopausal women].
Caserta L; Caserta R; Torella M; Perricone F; Nesti E; Sessa M; Tagliaferri A; De Francesco F; De Lucia D; Panariello S
Minerva Ginecol; 2004 Apr; 56(2):131-6. PubMed ID: 15258541
[TBL] [Abstract][Full Text] [Related]
7. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
[TBL] [Abstract][Full Text] [Related]
8. [Indications for hormone replacement therapy].
Birkhäuser MH
Ther Umsch; 2000 Oct; 57(10):635-42. PubMed ID: 11081375
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and venous thromboembolism.
Eisenberger A; Westhoff C
J Steroid Biochem Mol Biol; 2014 Jul; 142():76-82. PubMed ID: 24007716
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal hormone replacement therapy and venous thromboembolism.
Wu O
Gend Med; 2005; 2 Suppl A():S18-27. PubMed ID: 16551553
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy.
Lowe G; Woodward M; Vessey M; Rumley A; Gough P; Daly E
Thromb Haemost; 2000 Apr; 83(4):530-5. PubMed ID: 10780311
[TBL] [Abstract][Full Text] [Related]
12. Hormones and venous thromboembolism among postmenopausal women.
Scarabin PY
Climacteric; 2014 Dec; 17 Suppl 2():34-7. PubMed ID: 25223916
[TBL] [Abstract][Full Text] [Related]
13. Progestogens and venous thromboembolism among postmenopausal women using hormone therapy.
Canonico M; Plu-Bureau G; Scarabin PY
Maturitas; 2011 Dec; 70(4):354-60. PubMed ID: 22024394
[TBL] [Abstract][Full Text] [Related]
14. Hormone therapy and venous thromboembolism among postmenopausal women.
Scarabin PY
Front Horm Res; 2014; 43():21-32. PubMed ID: 24943295
[TBL] [Abstract][Full Text] [Related]
15. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
Norman RJ; Flight IH; Rees MC
Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
[TBL] [Abstract][Full Text] [Related]
16. Hormone therapy and thromboembolic disease.
Battaglioli T; Martinelli I
Curr Opin Hematol; 2007 Sep; 14(5):488-93. PubMed ID: 17934355
[TBL] [Abstract][Full Text] [Related]
17. Menopausal hormone therapy and risk of venous thromboembolism: The story so far.
Abdelhafez MMA; Ahmed KAM; Ahmed NAM; Ismail MH; Daud MNM; Eldiasty AME; Amri MFB; Jeffree MS; Masnah FK; Baharuddin DMP; Bolong MF; Hayati MF; Azizan NB; Sumpat D; Abdul Rahim SSS; Than WW; Ibrahim MY; Lo ZZ; Soe MZ
Afr J Reprod Health; 2024 Mar; 28(3):122-129. PubMed ID: 38583076
[TBL] [Abstract][Full Text] [Related]
18. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
Archer DF; Oger E
Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
[TBL] [Abstract][Full Text] [Related]
19. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
[TBL] [Abstract][Full Text] [Related]
20. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
Lacut K; Oger E
Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
